0001213900-23-019384.txt : 20230313 0001213900-23-019384.hdr.sgml : 20230313 20230313080020 ACCESSION NUMBER: 0001213900-23-019384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisman Harlan F CENTRAL INDEX KEY: 0001555563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 23725755 MAIL ADDRESS: STREET 1: C/O CORONADO BIOSCIENCES, INC. STREET 2: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0306 4 2023-03-10 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001555563 Weisman Harlan F 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 1 1 0 0 President and CEO Common Stock 2023-03-10 4 P 0 150000 0.8789 A 214615 D The reported shares were purchased in the open market in one transaction at the price of $0.8789. /s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact 2023-03-13